|
Si vous ne visualisez pas correctement ce message, cliquez ici
|
|
|
|
|
|
|
Newsletter #2
March 8th, 2023
|
|
|
|
|
Dear {Name},
it's an exciting time to be in our network! Our first postdoc fellowship call is about to close, our first equipment call is opening and a PhD fellowship call is in the making. We are also diving in the deep of our structuring projects, the collective intelligence digital platform and the distributed biofoundry. Find out everything in the email below and remember to forward this email to your contacts, especially young researchers!
|
|
|
|
|
|
|
I'm currently experiencing a serious issue with my e-mail, chiara.fracassi@u-paris.fr, which has been down since Feb 28th. If you wrote me there in the last week, I never received your message. While I'm trying to solve the issue, please contact me through my backup address chiara.fracassi@cri-paris.org
|
|
|
|
|
|
|
Postdoc fellowships call ends on March 13th
Only few days left to apply! The call will fund three 2-year fellowships in the field of synthetic biology for health.
|
|
|
|
|
|
|
|
Our 2023 equipment call is open!
We will finance small to medium equipment for labs working in biotherapy or bioproduction. The call is open until May 22nd.
|
|
|
|
|
|
|
|
|
Call for volunteers!
One of the main projects of our DIM is to develop a digital platform that can help researchers in our community to find collaborations, share expertise and skills, find funding opportunities and much more. We're looking for DIM members who'd like to give their input to the design of the platform!
|
|
|
|
|
|
|
|
TRAININGS - 3rd Bioprocessing and Manufacturing of Gene and Cell Therapy Products Course: attend for free
The DIM will sponsor up to 5 participants (for a value of 1000€ per ticket) to this cutting-edge course held in Spain on Sept 24-28, 2023, and organised by the European Society for Animal Cell Technology (ESACT).
This course is intended for Ph.D. students, post-docs, junior scientists, engineers and clinicians searching to improve their understanding of the development and manufacturing of gene and cell therapy products.
|
|
|
|
|
|
|
|
The call for the PRPhD 2023 programme is open
|
|
|
|
|
Testimonial: my first steps in innovation
Read about the experience of two academic researchers taking their first steps into the world of innovation
|
|
|
|
|
|
Other calls that you could find usefulDon't hesitate to follow Medicen Paris Région, competitivity hub of the Région Ile-de-France, whom you can contact for help if you wish to apply.
|
|
|
|
i-Demo Régionalisésupports experimental development projects and
of industrial innovation, ambitious and supported by SMEs, ETIs and GEs in connection
with academic research
|
|
|
|
Up to 2M€ in aid
intended to promote the emergence and development of places
of major innovation or of regional interest.
|
|
|
|
to catalyze and maintain excellence in biotherapy research by accelerating technology transfer and innovations, from the bench to the patient's bedside.
|
|
|
SESAME Filièrefor the structuring of strategic Ile-de-France sectors and the development of technological platforms open to SMEs/ETIs
|
|
|
|
i-DemoThis mechanism supports the development of very innovative products or services with high added value, in order to strengthen the French scientific and technological base.
|
|
|
France 2030 «Première Usine»The expected projects consist of setting up pilot sites and/or industrial production, intended to market innovative products. The expected budget should be >5M€
|
|
|
Recherche Hospitalo-Universitaire en SantéThe expected projects must have a strong potential for rapid transfer to the practice of care or industrial production and must be carried out by teams located in a health establishment.
|
|
|
Industrialisation et Capacités Santé 2030This call aims to support industrialization projects in the sectors of biotherapy and bioproduction of innovative therapies, the fight against emerging infectious diseases and CBRN threats, and medical devices and in vitro diagnostic devices.
|
|
|
|
|
|
|
Recent publications
Do you want to see your paper featured in our next newlsetter? Write to chiara.fracassi@u-paris.fr
Buffa, V., Alvarez Vargas, J.R., Galy, A., Spinozzi, S., Rocca, C.J., 2023. Hematopoietic stem and progenitors cells gene editing: Beyond blood disorders. Front. Genome Ed. 4, 997142. https://doi.org/10.3389/fgeed.2022.997142
|
|
|
Bui, S., Dancourt, J., Lavieu, G., 2023. Virus-Free Method to Control and Enhance Extracellular Vesicle Cargo Loading and Delivery. ACS Appl. Bio Mater. acsabm.2c00955. https://doi.org/10.1021/acsabm.2c00955
|
|
|
Dancourt, J., Piovesana, E., Lavieu, G., 2023. Efficient cell death mediated by bioengineered killer extracellular vesicles. Sci Rep 13, 1086. https://doi.org/10.1038/s41598-023-28306-8
|
|
|
Michaudel, C., Danne, C., Agus, A., Magniez, A., Aucouturier, A., Spatz, M., Lefevre, A., Kirchgesner, J., Rolhion, N., Wang, Y., Lavelle, A., Galbert, C., Da Costa, G., Poirier, M., Lapière, A., Planchais, J., Nádvorník, P., Illes, P., Oeuvray, C., Creusot, L., Michel, M.-L., Benech, N., Bourrier, A., Nion-Larmurier, I., Landman, C., Richard, M.L., Emond, P., Seksik, P., Beaugerie, L., Arguello, R.R., Moulin, D., Mani, S., Dvorák, Z., Bermúdez-Humarán, L.G., Langella, P., Sokol, H., 2022. Rewiring the altered tryptophan metabolism as a novel therapeutic strategy in inflammatory bowel diseases. Gut gutjnl-2022-327337. https://doi.org/10.1136/gutjnl-2022-327337
|
|
|
Peña, N.O., Cherukula, K., Even, B., Ji, D.-K., Razafindrakoto, S., Peng, S., Silva, A.K.A., Moyon, C.M., Hillaireau, H., Bianco, A., Fattal, E., Alloyeau, D., Gazeau, F., n.d. Resolution of MoS2 Nanosheets-induced Pulmonary Inflammation Driven by Nanoscale Intracellular Transformation and Extracellular-vesicle Shuttles. Advanced Materials n/a, 2209615. https://doi.org/10.1002/adma.202209615
|
|
|
Pouzet, S., Cruz-Ramón, J., Le Bec, M., Cordier, C., Banderas, A., Barral, S., Castaño-Cerezo, S., Lautier, T., Truan, G., Hersen, P., 2023. Optogenetic control of beta-carotene bioproduction in yeast across multiple lab-scales. Frontiers in Bioengineering and Biotechnology 11.
https://www.frontiersin.org/articles/10.3389/fbioe.2023.1085268 |
|
|
Sobrino, S., Magnani, A., Semeraro, M., Martignetti, L., Cortal, A., Denis, A., Couzin, C., Picard, C., Bustamante, J., Magrin, E., Joseph, L., Roudaut, C., Gabrion, A., Soheili, T., Cordier, C., Lortholary, O., Lefrere, F., Rieux-Laucat, F., Casanova, J.-L., Bodard, S., Boddaert, N., Thrasher, A.J., Touzot, F., Taque, S., Suarez, F., Marcais, A., Guilloux, A., Lagresle-Peyrou, C., Galy, A., Rausell, A., Blanche, S., Cavazzana, M., Six, E., 2023. Severe hematopoietic stem cell inflammation compromises chronic granulomatous disease gene therapy. Cell Reports Medicine 100919. https://doi.org/10.1016/j.xcrm.2023.100919
|
|
|
Tesson, F. & Bernheim, A. Synergy and regulation of antiphage systems: toward the existence of a bacterial immune system? Current Opinion in Microbiology 71, 102238 (2023).
https://doi.org/10.1016/j.mib.2022.102238 |
|
|
|
|
Pour vous désinscrire, cliquer ici
|
|
|
|
|
